作者
Kenan Aksu, Ayhan Donmez, Gokhan Keser
发表日期
2012/4/1
来源
Current pharmaceutical design
卷号
18
期号
11
页码范围
1478-1493
出版商
Bentham Science Publishers
简介
Although inflammation-induced thrombosis is a well-known entity, its pathogenesis remains complicated. There are complex interactions between inflammation and hemostasis, involving proinflammatory cytokines, chemokines, adhesion molecules, tissue factor expression, platelet and endothelial activation, and microparticles. Inflammation increases procoagulant factors, and also inhibits natural anticoagulant pathways and fibrinolytic activity, causing a thrombotic tendency. Besides, chronic inflammation may cause endothelial damage, resulting in the loss of physiologic anticoagulant, antiaggregant and vasodilatory properties of endothelium. However, inflammation- induced venous thrombosis may develop even in the absence of vessel wall damage. On the other hand, coagulation also augments inflammation, causing a vicious cycle. This is mainly achieved by means of thrombin-induced secretion of …
引用总数
2011201220132014201520162017201820192020202120222023202415203325232627222833474316
学术搜索中的文章